

Antibody pharmacophore (SMAP) small molecules
(1) Identify key residues from monoclonal antibody (mAb)-immune checkpoint cocrystal structure, then move on to: (2) pharmacophore-based virtual screening, (3) hit validation, (4) hit-to-lead validation.

Molecular Imaging Innovations Institute (MI3)